Quarterly report · Q2
9989.TEDINET S100PMIV
Period2022-04-01 → 2022-09-30
Filed2022-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥339.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥648.7bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥326.8bn | 2021-04-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | ¥18.5bn | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥17.9bn | 2021-04-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥18.8bn | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥34.7bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥18.2bn | 2021-04-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥18.5bn | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥18.3bn | 2021-04-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥12.7bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥23.9bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥12.5bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥12.7bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥12.5bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥337.1bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥325.8bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥313.5bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥108.0bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥105.2bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥229.1bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥220.6bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥213.3bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥94.5bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥89.3bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥94.5bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥89.3bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥90.3bn | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥86.5bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥21.4bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥31.7bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥16.8bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥12.0bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥20.7bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥8.9bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥4.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥8.2bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥4.1bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥108.81 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥54.94 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥204.02 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥106.54 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥48.36 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥108.81 | 2022-04-01 → 2022-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥204.01 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥106.53 | 2021-04-01 → 2021-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 68.0% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 67.7% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 68.0% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 28
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥24.7bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥24.7bn |
| jpcrp040300-q2r_E03226-000Discount Storereportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥143.9bn |
| jpcrp040300-q2r_E03226-000Discount Storereportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥143.9bn |
| jpcrp040300-q2r_E03226-000Discount Storereportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥5m |
| jpcrp040300-q2r_E03226-000Discount Storereportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥6.7bn |
| jpcrp040300-q2r_E03226-000Drug Storereportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥220.0bn |
| jpcrp040300-q2r_E03226-000Drug Storereportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥195.3bn |
| jpcrp040300-q2r_E03226-000Drug Storereportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥24.7bn |
| jpcrp040300-q2r_E03226-000Drug Storereportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥11.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥363.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥339.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥24.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥18.5bn |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-09-30 | −¥22.9bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-09-30 | −¥22.9bn |
| jpcrp040300-q2r_E03226-000Discount Storereportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥134.1bn |
| jpcrp040300-q2r_E03226-000Discount Storereportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥134.1bn |
| jpcrp040300-q2r_E03226-000Discount Storereportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥6m |
| jpcrp040300-q2r_E03226-000Discount Storereportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥6.1bn |
| jpcrp040300-q2r_E03226-000Drug Storereportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥215.5bn |
| jpcrp040300-q2r_E03226-000Drug Storereportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥192.6bn |
| jpcrp040300-q2r_E03226-000Drug Storereportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥22.9bn |
| jpcrp040300-q2r_E03226-000Drug Storereportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥11.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-09-30 | ¥349.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-09-30 | ¥326.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥22.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-09-30 | ¥17.9bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 480
| Item | Context | Value | Unit |
|---|---|---|---|
| Payments of loans receivable inv cf | Prior1YTDDuration | -330000000 | JPY |
| Payments of loans receivable inv cf | CurrentYTDDuration | -126000000 | JPY |
| Collection of loans receivable inv cf | Prior1YTDDuration | － | JPY |
| Collection of loans receivable inv cf | CurrentYTDDuration | 3000000 | JPY |
| Payments for lease and guarantee deposits inv cf | Prior1YTDDuration | -324000000 | JPY |
| Payments for lease and guarantee deposits inv cf | CurrentYTDDuration | -503000000 | JPY |
| Proceeds from collection of lease and guarantee deposits inv cf | Prior1YTDDuration | 314000000 | JPY |
| Proceeds from collection of lease and guarantee deposits inv cf | CurrentYTDDuration | 558000000 | JPY |
| Other net inv cf | Prior1YTDDuration | -295000000 | JPY |
| Other net inv cf | CurrentYTDDuration | -967000000 | JPY |
| Net cash provided by used in investment activities | Prior1YTDDuration | -8913000000 | JPY |
| Net cash provided by used in investment activities | CurrentYTDDuration | -12048000000 | JPY |
| Cash dividends paid fin cf | Prior1YTDDuration | -4091000000 | JPY |
| Cash dividends paid fin cf | CurrentYTDDuration | -4208000000 | JPY |
| Purchase of treasury stock fin cf | Prior1YTDDuration | -0 | JPY |
| Purchase of treasury stock fin cf | CurrentYTDDuration | -0 | JPY |
| Proceeds from exercise of stock option fin cf | Prior1YTDDuration | 0 | JPY |
| Proceeds from exercise of stock option fin cf | CurrentYTDDuration | － | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration | -4091000000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | -4208000000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | 3800000000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | 5153000000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 86495000000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 89330000000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 90296000000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 94484000000 | JPY |
| Salaries allowances and bonuses sga | Prior1YTDDuration | 23445000000 | JPY |
| Salaries allowances and bonuses sga | CurrentYTDDuration | 23972000000 | JPY |
| Rent expenses sga | Prior1YTDDuration | 13608000000 | JPY |
| Rent expenses sga | CurrentYTDDuration | 14226000000 | JPY |
| Provision for directors bonuses sga | Prior1YTDDuration | 32000000 | JPY |
| Provision for directors bonuses sga | CurrentYTDDuration | 41000000 | JPY |
| Retirement benefit expenses sga | Prior1YTDDuration | 294000000 | JPY |
| Retirement benefit expenses sga | CurrentYTDDuration | 317000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E03226-000DrugStoreReportableSegmentsMember | 192631000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E03226-000DiscountStoreReportableSegmentsMember | 134122000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 326754000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 326754000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E03226-000DrugStoreReportableSegmentsMember | 22891000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E03226-000DiscountStoreReportableSegmentsMember | 6000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 22898000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -22898000000 | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E03226-000DrugStoreReportableSegmentsMember | 215523000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E03226-000DiscountStoreReportableSegmentsMember | 134129000000 | JPY |
| Net sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 349652000000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -22898000000 | JPY |
| Net sales | Prior1YTDDuration | 326754000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E03226-000DrugStoreReportableSegmentsMember | 11860000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |